BioSpace News Archive

Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it will increase production capacity of the company’s SARS-CoV-2 molecular diagnostic test on its Revogene® platform after receiving a $5.5M award from the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative and an additional grant from JobsOhio.

Siemens Healthineers uses the remote connectivity platform TeamViewer to support its imaging and laboratory diagnostic equipment worldwide and keep it operational.

A surgical team from NYU Langone Health performed a face and double hand transplant for a 22-year-old New Jersey resident severely burned in a horrific car crash.

iSpecimen today announced it has expanded its cellular biospecimen offerings by introducing new cryopreserved stem and immune cell products for life science research and preclinical drug development.

Positive Preclinical Data to be Submitted for Presentation or Publication in 1H 2021; Lead NK Cell Candidate On Track to Begin Clinic Trials in 2H 2021

Virta Health, the type 2 diabetes reversal leader, today announced the appointment of Alok Bhushan to Chief Financial Officer.

Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical industries, is proud to announce that President and CEO Scott Herskovitz has been elected as an at-large board director of the Bio-Process Systems Alliance (BPSA).

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the closing of its previously announced underwritten public offering of 1,040,000 shares of its common stock at a public offering price of $12.25 per share.

As COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) elected two new officers to its board of directors. Ramona Sequeira, president of Takeda Pharmaceuticals USA, Inc. was named chair-elect.